echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Mysterious immune cells may trigger inflammation in multiple sclerosis and other brain diseases

    Mysterious immune cells may trigger inflammation in multiple sclerosis and other brain diseases

    • Last Update: 2022-01-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to a new study by researchers from the Weill Cornell School of Medicine and the New York Presbyterian Church, a group of immune cells can prevent gastrointestinal inflammation under normal conditions, but is associated with multiple sclerosis (MS) and other brain inflammations.
    The opposite effect may be produced in disease
    .


    Research results indicate that inhibiting the activity of these cells may be a new way to treat such diseases


    The researchers published their findings in the journal Nature on December 1, 2021, when they were studying a type of immune cell called group 3 innate lymphocytes (ilc3), which helps the immune system tolerate Beneficial microorganisms, and inhibit inflammation of the intestines and other organs throughout the body
    .


    They discovered a unique subgroup of these ilc3s that circulate in the blood and can penetrate into the brain-to their surprise, it did not extinguish inflammation, but ignited it


    Scientists call this subset of inflammatory ILC3s and found that they model the state of the central nervous system in mice instead of suppressing the immune response.


    This subset of ILC3s prompts another group of immune cells called T cells to attack myelinated nerve fibers, resulting in Symptoms of MS-like disease


    "This work has the potential to help us understand and treat a variety of conditions involving T cell infiltration," said senior author Dr.
    Gregory Sonnenberg, a medical microbiologist in gastroenterology and hepatology.
    And associate professor of immunology, and a member of the Jill Roberts Institute of Inflammatory Bowel Disease at Weill Cornell School of Medicine
    .

    Multiple sclerosis affects more than 2 million people worldwide
    .


    Other diseases characterized by chronic brain inflammation afflict tens of millions of people, including Alzheimer's and Parkinson's


    Researchers have found in recent studies that ilc3 in the intestines acts as a sentinel and immunomodulatory factor, which can inhibit inflammation, including inflammatory T cell activity, and can also prevent cancer
    .


    In the new study, they examined the role of ilc3 in the brain and found that, contrary to their expectations, under healthy conditions, ilc3 is usually not present in the brain, but during inflammation, ilc3 can penetrate from the blood.


    The researchers showed that in the mouse model of the lady, these inflammatory ILC3s brain functions as antigen presenting cells": They showed the main component of myelin protein, the insulating layer around nerve fibers, and the myelin T cells-prompting them to attack and cause disease signs of nerve damage
    .


    they found that the brains of mice with inflammatory ilc3 active in T cell inflammation and damage nerves in the area are closely related


    "The penetration of these inflammatory ILC3s into the brain and spinal cord of mice is consistent with the onset and peak of the disease," said first author John Benji Grieg, who is the laboratory of Sonnenberg at Will Cornell University.
    Doctoral student of the Graduate School of Medical Sciences
    .


    "In addition, our experimental data in mice shows that these immune cells play a key role in driving the pathogenesis of neuroinflammation


    Researchers found that they can prevent MS-like diseases in animals by removing a key molecule called MHCII from ilc3.
    This molecule is usually used in the antigen presentation process.
    Removing MHCII essentially prevents cells from activating and attacking the marrow.
    The ability to sheath T cells
    .

    "Although we have the best disease-modifying therapy for multiple sclerosis, the patient's condition continues to develop, and because of the early onset of the disease, they face the prospect of permanent physical and cognitive disability," Professor of Neuroscience Dr.
    Tim Vartanian, co-author, said Feil Family Brain and Thinking Institute Weill Cornell Medical Division Chief Multiple Sclerosis and Neuro-immunology Neurology and Neurology Professor at New York Presbyterian Hospital/Will Cornell Medicine and Weill Cornell Medical Center
    .


    "The identification of inflammatory ilc3 with antigen-presenting ability in the central nervous system of patients with multiple sclerosis provides a new strategic goal for the prevention of nervous system damage


    Finally, the researchers found that ilc3 in other tissues in the body can be programmed to effectively combat the activity of T cells infiltrated in the brain, thereby preventing MS diseases in mice
    .

    This work was done in close collaboration with Dr.
    Ari Waisman, Director of the Institute of Molecular Medicine at the Johannes Gutenberg University Medical Center in Mainz.
    Based on previous studies, the researchers proved that there is ilc3 in the intestine, which is slightly different.
    In order to promote the inactivation or "tolerance" of T cells, the antigen is displayed to T cells in a way
    .
    Researchers have demonstrated through experiments that by exposing these tolerance-inducing intestinal ilc3 to myelin, they can prevent neuroinflammatory T cell activity and the development of ms-like diseases in mice
    .

    Dr.
    Sonnenberg said that this work therefore points to the possibility that one day, by directly inhibiting the activity of inflammatory ilc3 that infiltrates the brain, or by targeting autoantigens to intestinal ilc3 that promotes tolerance to other tissues, it can be treated.
    Multiple sclerosis and many other potentially inflammatory diseases
    .

    references:

    "Antigen-presenting innate lymphoid cells orchestrate neuroinflammation" by John B.
    Grigg, Arthi Shanmugavadivu, Tommy Regen, Christopher N.
    Parkhurst, Anees Ahmed, Ann M.
    Joseph, Michael Mazzucco, Konrad Gronke, Andreas Diefenbach, Gerard Eberl, Timothy Vartanian, Ari Waisman and Gregory F.
    Sonnenberg, 1 December 2021,  Nature .

    DOI: 10.
    1038/s41586-021-04136-4

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.